MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gajate, C.
Right arrow Articles by Mollinedo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gajate, C.
Right arrow Articles by Mollinedo, F.

Vol. 53, Issue 4, 602-612, April 1998

Involvement of c-Jun NH2-Terminal Kinase Activation and c-Jun in the Induction of Apoptosis by the Ether Phospholipid 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine

Consuelo Gajate, Antonio Santos-Beneit, Manuel Modolell, and Faustino Mollinedo

Laboratory of Signal Transduction and Leukocyte Biology (C.G., A.S-B., F.M.), Instituto de Biología y Genética Molecular, Facultad de Medicina, Consejo Superior de Investigaciones Científicas-Universidad de Valladolid, E-47005 Valladolid, Spain, and Max-Planck-Institut für Immunbiologie (M.M.), D-79108 Freiburg, Germany

The ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3; edelfosine) is a potent inducer of apoptosis in human tumor cells. We show that ET-18-OCH3-induced apoptosis is associated with activation of the c-Jun NH2-terminal kinase (JNK) signaling. The addition of ET-18-OCH3 to distinct human leukemic cells (HL-60, U937, and Jurkat), which undergo rapid apoptosis on treatment with ET-18-OCH3, induced a dramatic and sustained increase in the of c-jun mRNA level that was associated with activation of activator protein-1 transcription factor. We found that ET-18-OCH3 induced a persistent activation of JNK in HL-60 cells that was detected before the onset of apoptosis, the latter being assessed by DNA fragmentation and by the appearance of phosphatidylserine on the external leaflet of the plasma membrane. The inductions of JNK after HL-60 monocyte/macrophage differentiation and ET-18-OCH3-mediated apoptosis were distinguished by the different activation patterns, transient versus persistent, respectively. ET-18-OCH3 analogues unable to induce apoptosis failed to activate JNK. ET-18-OCH3-dependent JNK activation was not detected in K562 cells, which did not undergo apoptosis on treatment with ET-18-OCH3. Phorbol myristate acetate inhibited both ET-18-OCH3-induced apoptosis and sustained JNK activation; thus, persistent JNK activation by ET-18-OCH3 is associated with the capacity of this ether phospholipid to induce apoptosis. Furthermore, antisense oligonucleotides directed against c-jun blocked ET-18-OCH3-induced apoptosis, indicating a role for c-Jun in this apoptotic response. These data indicate that JNK activation and c-Jun are involved in the induction of apoptosis by ET-18-OCH3.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Nieto-Miguel, R. I. Fonteriz, L. Vay, C. Gajate, S. Lopez-Hernandez, and F. Mollinedo
Endoplasmic Reticulum Stress in the Proapoptotic Action of Edelfosine in Solid Tumor Cells
Cancer Res., November 1, 2007; 67(21): 10368 - 10378.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nieto-Miguel, C. Gajate, and F. Mollinedo
Differential Targets and Subcellular Localization of Antitumor Alkyl-lysophospholipid in Leukemic Versus Solid Tumor Cells
J. Biol. Chem., May 26, 2006; 281(21): 14833 - 14840.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Gajate, E. del Canto-Janez, A. U. Acuna, F. Amat-Guerri, E. Geijo, A. M. Santos-Beneit, R. J. Veldman, and F. Mollinedo
Intracellular Triggering of Fas Aggregation and Recruitment of Apoptotic Molecules into Fas-enriched Rafts in Selective Tumor Cell Apoptosis
J. Exp. Med., August 2, 2004; 200(3): 353 - 365.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
L. Bey, N. Akunuri, P. Zhao, E. P. Hoffman, D. G. Hamilton, and M. T. Hamilton
Patterns of global gene expression in rat skeletal muscle during unloading and low-intensity ambulatory activity
Physiol Genomics, April 16, 2003; 13(2): 157 - 167.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Gajate, F. An, and F. Mollinedo
Rapid and Selective Apoptosis in Human Leukemic Cells Induced by Aplidine through a Fas/CD95- and Mitochondrial-mediated Mechanism
Clin. Cancer Res., April 1, 2003; 9(4): 1535 - 1545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Gajate, F. An, and F. Mollinedo
Differential Cytostatic and Apoptotic Effects of Ecteinascidin-743 in Cancer Cells. TRANSCRIPTION-DEPENDENT CELL CYCLE ARREST AND TRANSCRIPTION-INDEPENDENT JNK AND MITOCHONDRIAL MEDIATED APOPTOSIS
J. Biol. Chem., October 25, 2002; 277(44): 41580 - 41589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. B. Maggi Jr., J. M. Moran, A. L. Scarim, D. A. Ford, J.-W. Yoon, J. McHowat, R. M. L. Buller, and J. A. Corbett
Novel Role for Calcium-independent Phospholipase A2 in the Macrophage Antiviral Response of Inducible Nitric-oxide Synthase Expression
J. Biol. Chem., October 4, 2002; 277(41): 38449 - 38455.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Gajate, I. Barasoain, J. M. Andreu, and F. Mollinedo
Induction of Apoptosis in Leukemic Cells by the Reversible Microtubule-disrupting Agent 2-Methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: Protection by Bcl-2 and Bcl-XL and Cell Cycle Arrest
Cancer Res., May 1, 2000; 60(10): 2651 - 2659.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
M. Matsuoka, B. Wispriyono, Y. Iryo, and H. Igisu
Mercury Chloride Activates c-Jun N-Terminal Kinase and Induces c-jun Expression in LLC-PK1 Cells
Toxicol. Sci., February 1, 2000; 53(2): 361 - 368.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Satomi, S. Miyamoto, and M. N. Gould
Induction of AP-1 activity by perillyl alcohol in breast cancer cells
Carcinogenesis, October 1, 1999; 20(10): 1957 - 1961.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
Rosie Xing and R. Kolesnick
Stress signaling of apoptosis via ceramide and c-jun kinase
Innate Immunity, August 1, 1999; 5(4): 216 - 221.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
V. I. Shifrin and P. Anderson
Trichothecene Mycotoxins Trigger a Ribotoxic Stress Response That Activates c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase and Induces Apoptosis
J. Biol. Chem., May 14, 1999; 274(20): 13985 - 13992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yang, J.-Z. Cheng, S. S. Singhal, M. Saini, U. Pandya, S. Awasthi, and Y. C. Awasthi
Role of Glutathione S-Transferases in Protection against Lipid Peroxidation. OVEREXPRESSION OF hGSTA2-2 IN K562 CELLS PROTECTS AGAINST HYDROGEN PEROXIDE-INDUCED APOPTOSIS AND INHIBITS JNK AND CASPASE 3 ACTIVATION
J. Biol. Chem., May 25, 2001; 276(22): 19220 - 19230.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics